Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Mar 11, 2016 (11 years ago)

Sodium Iodide I 131 Capsule

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Label Error on Declared Strength

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05

Affected NDC 65174-0461-05

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sodium Iodide I 131 Diagnostic
Sodium Iodide I 131
NDC 65174-0461
SODIUM IODIDE I-131 100 mCi/1 Capsule
Oral
Jubilant DraxImage Inc., dba Jubilant Radiopharma Rx
Recalling firm
Jubilant Draximage Inc
NDC code
65174-461-05
Origin
N/A, Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0812-2016 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Jubilant Draximage Inc

All 2016 recalls
Class II · Moderate risk

Draximage MAA

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Terminated Sterility / contamination Jubilant Draximage Inc NDC 65174-270-30 D-1189-2022

Other labeling / mix-up recalls from 2016

All labeling / mix-up recalls
Class III · Low risk

Amoxicillin for Oral suspension

Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.

Terminated Labeling / mix-up West-Ward Pharmaceuticals Corp. NDC 0143-9887-01 D-0147-2017